Fuzhenghuayu ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
93	Primary biliary cholangitis	2

93. Primary biliary cholangitis

---

Clinical trials : 298 /  Drugs : 252 - (DrugBank : 59) / Drug target genes : 35 - Drug target pathways : 115

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02916641 (ClinicalTrials.gov)	January 2016	28/1/2016	Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid		Primary Biliary Cirrhosis	Drug: Fuzhenghuayu;Drug: UDCA	Xijing Hospital of Digestive Diseases	NULL	Recruiting	18 Years	70 Years	Both	200	Phase 3	China
2	NCT02916290 (ClinicalTrials.gov)	January 2016	28/1/2016	Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis		Primary Biliary Cirrhosis	Drug: Fuzhenghuayu;Drug: UDCA	Xijing Hospital of Digestive Diseases	NULL	Recruiting	18 Years	70 Years	Both	200	Phase 3	China